News from Holden

Research

Holden oncologist Muhammad Furqan, MD, receives NCI award for dedication to lung cancer clinical research

Muhammad Furqan, MD, medical oncologist in the University of Iowa Holden Comprehensive Cancer Center, is the recipie

Innovation

Rare cancer care

Treating two girls with the same rare cancer is more than a coincidence for UI adult and pediatric specialists.

Innovation Research

Bladder cancer breakthrough

With the conventional first-line drug for early-stage bladder cancer in severe shortage, new therapies developed at Iowa are poised to lead a new wave of care.

From the Director

Weiner to step down as director of Holden Comprehensive Cancer Center March 31; Henry to serve as interim director

George Weiner, MD, director of University of Iowa Holden Comprehensive Cancer Center, will step down from the leaders

Innovation

Caris’ Precision Oncology Alliance Welcomes University of Iowa Holden Comprehensive Cancer Center

Holden Cancer Center joins Caris’ extensive network of leading cancer institutions committed to utilizing clinical

Innovation

Holden Comprehensive Cancer Center among nation’s top cancer organizations to issue joint call to action for increased lung cancer screening

University of Iowa’s Holden Comprehensive Cancer Center has partnered with more than 50 cancer organizations to issue a call to action urging individuals, providers and insurers to increase access to and utilization of low-dose computed tomography (CT) scans for those at high risk for lung cancer.

Innovation

Unique bone cancer treatment is customized to each patient’s anatomy

The treatment uses 3D technology to precisely map tumor removal and develop prosthetics that are unique to each patient’s anatomy. It’s helping patients get back to their active lifestyles sooner.